Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells

The glycolytic phenotype of ovarian cancer cells can be targeted for therapeutic intervention. Combined treatment modalities that target multiple cellular pathways hold promise for the treatment of chemoresistant ovarian cancer cells.